These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 31567920)

  • 1. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
    Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Systemic Inflammation Indices by K-ras Status in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Akiyama T; Kato R; Sawayama H; Ogawa K; Yoshida N; Baba H
    Dis Colon Rectum; 2023 Aug; 66(8):e809-e817. PubMed ID: 35195557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Nutritional Scores as Host-Related Prognostic Factors for Both Overall Survival and Postoperative Complications in Patients With Stage II to III Colorectal Cancer.
    Ahiko Y; Shida D; Nakamura Y; Imaizumi J; Takamizawa Y; Moritani K; Tsukamoto S; Kanemitsu Y
    Dis Colon Rectum; 2021 Oct; 64(10):1222-1231. PubMed ID: 33951689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
    Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
    Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients With Colorectal Cancer After Surgical Resection.
    Kusunoki K; Toiyama Y; Okugawa Y; Yamamoto A; Omura Y; Ohi M; Araki T; Kusunoki M
    Dis Colon Rectum; 2020 Sep; 63(9):1242-1250. PubMed ID: 33216495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
    Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
    Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
    Lim YJ; Song C; Jeon SH; Kim K; Chie EK
    Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
    You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
    Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of an Enhanced Recovery Protocol Is Associated With On-Time Initiation of Adjuvant Chemotherapy in Colorectal Cancer.
    Hassinger TE; Mehaffey JH; Martin AN; Bauer-Nilsen K; Turrentine FE; Thiele RH; Sarosiek BM; Reilley MJ; Hoang SC; Friel CM; Hedrick TL
    Dis Colon Rectum; 2019 Nov; 62(11):1305-1315. PubMed ID: 31567924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
    Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
    Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
    Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
    Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.
    Takamizawa Y; Shida D; Horie T; Tsukamoto S; Esaki M; Shimada K; Kondo T; Kanemitsu Y
    Dis Colon Rectum; 2023 Feb; 66(2):233-242. PubMed ID: 35714342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon Cancer.
    Inoue H; Kudou M; Shiozaki A; Kosuga T; Shimizu H; Kiuchi J; Arita T; Konishi H; Komatsu S; Kuriu Y; Morinaga Y; Konishi E; Otsuji E
    Dis Colon Rectum; 2023 Nov; 66(11):1449-1461. PubMed ID: 36649165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
    Hagerty BL; Aversa JG; Dominguez DA; Davis JL; Hernandez JM; McCormick JT; Blakely AM
    Dis Colon Rectum; 2022 Oct; 65(10):1206-1214. PubMed ID: 34897212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
    Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
    Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy.
    Kobayashi Y; Shida D; Boku N; Yasui K; Nakamura Y; Kudose Y; Imaizumi J; Kanemitsu Y
    Dis Colon Rectum; 2023 Mar; 66(3):401-409. PubMed ID: 35239524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Enlarged Lymph Nodes in Stage II Colorectal Cancer.
    Matsunaga K; Sasaki K; Nozawa H; Kawai K; Murono K; Yamauchi S; Sugihara K; Ishihara S
    Dis Colon Rectum; 2023 Nov; 66(11):e1097-e1106. PubMed ID: 37603828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.